Company news

TheraCryf PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Result of General Meeting & Total Voting Rights

March 3, 2021

Update on patient recruitment

February 17, 2021

Posting of Circular & Notice of GM

February 12, 2021

Placing and Open Offer to raise up to £11 million

February 2, 2021

Preclinical data on a new therapeutic target

January 22, 2021

Positive pre-clinical data for lead asset SFX-01

January 21, 2021

Patient recruitment update in STAR-COVID 19 trial

January 19, 2021

Recruitment of first patient in STAR trial

November 23, 2020

Comment on the COVID-19 vaccine announcement

November 11, 2020

All approvals received for STAR trial to commence

October 23, 2020

Grant of options

October 6, 2020

Appointment of Chief Executive Officer

September 24, 2020

Licence agreement with Juvenescence

September 15, 2020

Share option exercise and issue of equity

July 24, 2020

SFX-01 to be evaluated in COVID-19 trial

June 17, 2020

Paper on SFX-01 in ER positive breast cancer

June 8, 2020

Statement Re: Share Price Movement

May 15, 2020

Directorate Change

April 30, 2020

University of Rochester Collaboration

February 13, 2020

University of Manchester collaboration discovery

February 6, 2020

Investor presentation

December 17, 2019

MOU with The University of Dundee

December 5, 2019

SAS study clarification

November 11, 2019

ESMO presentation of Phase II STEM clinical data

September 30, 2019

Update on extended-use phase of STEM trial

September 23, 2019

Agreement for supply of SFX-01 for autism trial

September 5, 2019

Update on SAS study

August 28, 2019

Grant of further European patent

August 7, 2019

Research collaboration

August 5, 2019

AGM Statement

July 18, 2019

SFX-01 featured in SAH review paper

June 24, 2019

Posting of Annual Report and AGM Notice

June 19, 2019

Notification of Preliminary Results

June 11, 2019

Share Option Exercise and Issue of Equity

May 21, 2019

Result of GM and Completion of Placing

May 8, 2019

Posting of Circular and Timing of General Meeting

April 18, 2019

Placing and Notice of General Meeting

April 17, 2019

finnCap publishes initiation research

April 2, 2019

Poster presentation of Imperial College data

March 28, 2019

SFX-01 meets primary endpoints in STEM trial

March 25, 2019

Update on SFX-01 trial read-out dates

March 18, 2019

SFX-01 data published in peer reviewed journal

March 5, 2019

Clinical trial update confirms read-outs on track

February 5, 2019

SFX-01 featured in Nature Reviews Drug Discovery

January 23, 2019

Interim Results

December 12, 2018

Nominated Adviser Status

December 10, 2018

Poster Presentation of SFX-01 and Trial Update

December 4, 2018

Notification of Half Year Results

December 3, 2018

Investor Presentation in Manchester

November 19, 2018

Placing

October 18, 2018

← Newer news releases · Older news releases →

Calls

The 5 newest of 12 calls. Every call is listed under its year.

Decks

The 5 newest of 15 decks. Every deck is listed under its year.